HLUBFH. Lundbeck A/S

About H. Lundbeck A/S (HLUBF)

H. Lundbeck A/S (HLUBF) is a Drug Manufacturers - Specialty & Generic company headquartered in Valby, Denmark whose shares trade over-the-counter on the Pink tier.

Lundbeck is a global pharmaceutical company highly committed to improving the quality of life for people suffering from brain diseases. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company's products are targeted at diseases such as depression and anxiety, psychotic diseases, epilepsy and Huntington's, Alzheimer's and Parkinson's diseases.

HLUBF key facts

Ticker symbol

HLUBF

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Valby, Denmark

Country of incorporation

DK

Year of incorporation

1999

Employees

5,800

Reporting standard

International Reporting: Bern eXchange

Audit status

Audited

Fiscal year end

12/31

H. Lundbeck A/S leadership

• Ulf Wiinberg — CEO
• Anders Gotzsche — CFO
• Magnus Jensen — IR

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with H